 Marinus Pharmaceuticals, Inc. NASDAQ:MRNS Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Sasha Damouni Ellis Vice President-Corporate Affairs and Investor Relations Scott Braunstein Chief Executive Officer Christy Shafer Chief Commercial Officer Joe Hulihan Chief Medical Officer Steve Pfanstiel Chief Financial Officer Conference Call Participants Joseph Thome Cowen and Company Andrew Tsai Jefferies Douglas Tsao H.C. Wainwright Jay Olson Oppenheimer Operator Ladies and gentlemen, greetings and welcome to the Marinus Pharmaceuticals Third Quarter 2022 Financial Results and Business Update Call. 